N-Nitroso Methyl Flecainide Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Flecainide is used to prevent and treat abnormally rapid heart rates, including conditions such as paroxysmal supraventricular tachycardia (PSVTs), Wolff-Parkinson-White syndrome, atrioventricular nodal re-entrant tachycardia (AVNRT), AV re-entrant tachycardia (AVRT), and atrial fibrillation/atrial flutter in patients.N-Nitroso Methyl Flecainide Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Methyl Flecainide Impurity CAS NO:NA chemically represented as N-((4-Methyl-1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide.Synchemia is the leading manufacturing and exporter of N-Nitroso Methyl Flecainide Impurity . We supply N-Nitroso Methyl Flecainide Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143779 |
| CAS No | NA |
| Mol.F. | C13H17N3O2 |
| Mol.Wt. | 247.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143780 |
| CAS No | 61578-30-1 |
| Mol.F. | C4H4D4N2O2 |
| Mol.Wt. | 120.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143781 |
| CAS No | NA |
| Mol.F. | C613CH13D3N2O6 |
| Mol.Wt. | 228.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143782 |
| CAS No | NA |
| Mol.F. | C7H13D3N2O6 |
| Mol.Wt. | 227.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143783 |
| CAS No | NA |
| Mol.F. | C614CH16N2O6 |
| Mol.Wt. | 226.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143784 |
| CAS No | 2124271-47-0 |
| Mol.F. | C22H21D4F2NO4 |
| Mol.Wt. | 409.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143785 |
| CAS No | NA |
| Mol.F. | C22H20D4F2N2O5 |
| Mol.Wt. | 438.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143786 |
| CAS No | 2747915-48-4 |
| Mol.F. | C22H21D4F2NO4 |
| Mol.Wt. | 409.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143787 |
| CAS No | NA |
| Mol.F. | C22H21D4F2NO4 |
| Mol.Wt. | 409.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143788 |
| CAS No | 1219166-00-3 |
| Mol.F. | C22H17D8F2NO4 |
| Mol.Wt. | 413.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143789 |
| CAS No | NA |
| Mol.F. | C28H25N5O4 |
| Mol.Wt. | 495.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143790 |
| CAS No | NA |
| Mol.F. | C17H24N2O4 |
| Mol.Wt. | 320.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143791 |
| CAS No | NA |
| Mol.F. | C13H13N3O6 : 2(Na) |
| Mol.Wt. | 307.3 : 2(23.0) g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143792 |
| CAS No | 19023-40-6 |
| Mol.F. | C12H15F3N2O |
| Mol.Wt. | 260.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143793 |
| CAS No | NA |
| Mol.F. | C16H22N2O4 |
| Mol.Wt. | 306.36 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143794 |
| CAS No | NA |
| Mol.F. | C21H18D5N5O3S |
| Mol.Wt. | 430.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |